GlassScriptPhysician profile
Sachin Bahl
NPI 1841377579
$161,708.73
in general payments reported to CMS, 2019-2025
55 companies · $5,656 in 2025
The $5,656 reported for 2025 was more than what 88% of Endocrinology, Diabetes & Metabolism providers received nationally (typical 2025 total: $506).
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,884 · 2020: $127K · 2021: $4,597 · 2022: $6,635 · 2023: $3,449 · 2024: $4,468 · 2025: $5,656.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,856 · Food and Beverage: $4,712 · Education: $4.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,856.25 |
| Food and Beverage | $4,712.11 |
| Education | $4.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $120,000.00 | 2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16,325.29 | 2019-2025 | Jardiance, Synjardy, Tradjenta |
| Lilly USA, LLC | $16,075.81 | 2019-2025 | Jardiance, Mounjaro, Zepbound |
| Sanofi-Aventis U.S. LLC | $1,230.79 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $1,201.67 | 2019-2024 | Farxiga, Airsupra, Breztri |
| Novo Nordisk INC | $1,143.09 | 2019-2025 | Wegovy, Ozempic, Saxenda |
| Bayer Healthcare Pharmaceuticals INC. | $817.61 | 2021-2025 | |
| Dexcom, INC. | $738.61 | 2020-2025 | Dexcom G6 Transmitter |
| Amgen INC. | $590.85 | 2019-2025 | Repatha, Evenity, Prolia |
| Amneal Pharmaceuticals LLC | $225.69 | 2020-2025 | Unithroid |
| Becton, Dickinson and Company | $221.54 | 2019-2022 | |
| Corcept Therapeutics | $214.00 | 2019-2025 | Korlym |
| Merck Sharp & Dohme LLC | $212.83 | 2019-2022 | |
| Mannkind Corporation | $191.48 | 2022-2023 | Afrezza |
| Medtronic, INC. | $188.70 | 2022-2025 | Minimed 780g, Inpen Smart Insulin Delivery System |
Show all 55 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $187.19 | 2021-2025 | Trelegy Ellipta |
| Insulet Corporation | $143.55 | 2019-2025 | Omnipod |
| Abbott Laboratories | $132.73 | 2019-2025 | Freestyle Libre 3 |
| E.R. Squibb & Sons, L.L.C. | $118.02 | 2020-2024 | Eliquis, Camzyos |
| Neurocrine Biosciences, INC. | $112.92 | 2025 | |
| Cequr Corporation | $108.29 | 2025 | Cequr Simplicity |
| Exact Sciences Corporation | $85.20 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Xeris Pharmaceuticals, INC. | $83.15 | 2021-2025 | Recorlev |
| Janssen Pharmaceuticals, INC | $75.63 | 2020 | |
| Alexion Pharmaceuticals, INC. | $71.00 | 2021-2025 | Strensiq |
| Ultragenyx Pharmaceutical INC. | $69.55 | 2022 | |
| Antares Pharma, INC. | $68.20 | 2019-2025 | Xyosted |
| Abbvie INC. | $66.78 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $62.39 | 2020-2021 | |
| Amarin Pharma, INC. | $62.02 | 2019-2021 | |
| Grifols USA, LLC | $61.13 | 2019-2021 | |
| Embecta Corp. | $60.42 | 2023 | Bd Nano 2nd Gen Pen Needle |
| Takeda Pharmaceuticals U.S.A., INC. | $59.85 | 2019-2020 | |
| Ascendis Pharma Endocrinology INC | $57.13 | 2023-2025 | Yorvipath |
| Medtronic Minimed, INC. | $54.25 | 2019-2020 | |
| Soleno Therapeutics, INC. | $53.69 | 2025 | Vykat Xr |
| Novartis Pharmaceuticals Corporation | $48.01 | 2021-2024 | |
| Pfizer INC. | $47.90 | 2019-2024 | |
| Arbor Pharmaceuticals, INC. | $44.66 | 2019-2020 | |
| Sequel Med Tech, LLC | $43.42 | 2025 | Twiist |
| Beta Bionics, INC. | $39.68 | 2024-2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Inset, Ilet Insulin Infusion Kit Contact Detach |
| Acella Pharmaceuticals, LLC | $39.28 | 2024-2025 | NP Thyroid 60 |
| Shire North American Group INC | $34.55 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $30.96 | 2021 | |
| Amphastar Pharmaceuticals, INC. | $26.77 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $24.08 | 2020 | |
| Halozyme INC | $20.14 | 2023 | |
| Aytu Biopharma, INC. | $19.50 | 2019 | |
| Verity Pharmaceuticals INC. | $18.37 | 2024 | Tlando |
| Recordati_rare_diseases_inc. | $18.27 | 2023 | Isturisa, Signifor Lar |
| Zealand Pharma US, INC. | $17.68 | 2022 | |
| Lifescan, INC. | $17.40 | 2020 | |
| Acerus Pharmaceuticals Corporation | $16.28 | 2021 | |
| Tandem Diabetes Care, INC. | $16.12 | 2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Madrigal Pharmaceuticals | $14.61 | 2025 | Rezdiffra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sachin Bahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.